Thomas Kergrohen

856 total citations
12 papers, 384 citations indexed

About

Thomas Kergrohen is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Thomas Kergrohen has authored 12 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Genetics and 3 papers in Oncology. Recurrent topics in Thomas Kergrohen's work include Glioma Diagnosis and Treatment (6 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Epigenetics and DNA Methylation (2 papers). Thomas Kergrohen is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Epigenetics and DNA Methylation (2 papers). Thomas Kergrohen collaborates with scholars based in France, United Kingdom and Sweden. Thomas Kergrohen's co-authors include Jacques Grill, Stéphanie Puget, David Castel, Pascale Varlet, Marie‐Anne Debily, Chris Jones, Stefan M. Pfister, Christof M. Kramm, David Jones and Kévin Beccaria and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Thomas Kergrohen

10 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Kergrohen France	8	217	211	111	59	52	12	384
I. Rojas-Marcos Spain	9	171 0.8×	191 0.9×	167 1.5×	74 1.3×	44 0.8×	22	440
Melissa M. Fraser United States	7	169 0.8×	272 1.3×	107 1.0×	42 0.7×	45 0.9×	7	464
Olivia Cobb United States	9	131 0.6×	106 0.5×	111 1.0×	58 1.0×	39 0.8×	14	363
Joseph Landolfi United States	9	149 0.7×	51 0.2×	151 1.4×	60 1.0×	50 1.0×	25	360
Astrid Nümann Germany	10	94 0.4×	223 1.1×	181 1.6×	25 0.4×	48 0.9×	13	469
Crystal White United Kingdom	6	85 0.4×	100 0.5×	170 1.5×	30 0.5×	69 1.3×	14	348
Makoto Kamiya Japan	10	103 0.5×	128 0.6×	59 0.5×	41 0.7×	35 0.7×	18	332
Michele Kyle United States	10	93 0.4×	164 0.8×	100 0.9×	28 0.5×	41 0.8×	20	404
Tim-Rasmus Kiehl United States	9	55 0.3×	199 0.9×	91 0.8×	25 0.4×	72 1.4×	9	381
Val Davison United Kingdom	7	98 0.5×	199 0.9×	33 0.3×	40 0.7×	36 0.7×	10	368

Countries citing papers authored by Thomas Kergrohen

Since Specialization

Citations

This map shows the geographic impact of Thomas Kergrohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kergrohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kergrohen more than expected).

Fields of papers citing papers by Thomas Kergrohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kergrohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kergrohen. The network helps show where Thomas Kergrohen may publish in the future.

Co-authorship network of co-authors of Thomas Kergrohen

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Kergrohen. A scholar is included among the top collaborators of Thomas Kergrohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Kergrohen. Thomas Kergrohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Kergrohen, Thomas, Ludivine Le Dret, Kévin Beccaria, et al.. (2023). VRK3 depletion induces cell cycle arrest and metabolic reprogramming of pontine diffuse midline glioma - H3K27 altered cells. Frontiers in Oncology. 13. 1229312–1229312.

Grill, Jacques, Gwénaël Le Teuff, Pascale Varlet, et al.. (2023). Biological medicines for diffuse intrinsic pontine glioma (DIPG) eradication (BIOMEDE): Final results of an international randomized phase II platform trial comparing 3 targeted therapies in combination with radiotherapy from ITCC, SIOPE-Brain and ANZCHOG.. Journal of Clinical Oncology. 41(16_suppl). 10003–10003. 3 indexed citations

Kergrohen, Thomas, et al.. (2022). ROCK: digital normalization of whole genome sequencingdata. The Journal of Open Source Software. 7(73). 3790–3790. 2 indexed citations

Bruschi, Marco, Laure Garnier, Michaël Dumas, et al.. (2020). Loss of Apc Rapidly Impairs DNA Methylation Programs and Cell Fate Decisions in Lgr5+ Intestinal Stem Cells. Cancer Research. 80(11). 2101–2113. 11 indexed citations

Castel, David, Thomas Kergrohen, Arnault Tauziède‐Espariat, et al.. (2020). Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation. Acta Neuropathologica. 139(6). 1109–1113. 102 indexed citations

Barret, E., Gwénaël Le Teuff, Jane Merlevede, et al.. (2019). TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG). Clinical Cancer Research. 25(22). 6788–6800. 62 indexed citations

Leblond, Claire S., Freddy Cliquet, Guillaume Huguet, et al.. (2019). Both rare and common genetic variants contribute to autism in the Faroe Islands. npj Genomic Medicine. 4(1). 1–1. 52 indexed citations

Barret, E., Jane Merlevede, Thomas Kergrohen, et al.. (2019). A kinome-wide shRNA screen uncovers vaccinia-related kinase 3 (VRK3) as an essential gene for diffuse intrinsic pontine glioma survival. Oncogene. 38(38). 6479–6490. 11 indexed citations

Debily, Marie-Anne, Thomas Kergrohen, Pascale Varlet, et al.. (2019). PDTM-36. WHOLE EXOME SEQUENCING (WES) OF DIPG PATIENTS FROM THE BIOMEDE TRIAL REVEALS NEW PROGNOSTIC SUBGROUPS WITH SPECIFIC ONCOGENIC PROGRAMMES. Neuro-Oncology. 21(Supplement_6). vi195–vi195.

10.

Gareton, Albane, Arnault Tauziède‐Espariat, Volodia Dangouloff‐Ros, et al.. (2019). The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population. Acta Neuropathologica. 139(2). 287–303. 23 indexed citations

11.

Castel, David, Cathy Philippe, Thomas Kergrohen, et al.. (2018). Transcriptomic and epigenetic profiling of ‘diffuse midline gliomas, H3 K27M-mutant’ discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location. Acta Neuropathologica Communications. 6(1). 117–117. 83 indexed citations

12.

Doyen, Antonia, Christophe Malabat, Bertrand Néron, et al.. (2018). Antisense transcriptional interference mediates condition-specific gene repression in budding yeast. Nucleic Acids Research. 46(12). 6009–6025. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact